| Filed On | Filing |
|---|---|
| 14 Feb 2024 |
Form 5: Spears Stephan Michael, VP Corporate Development
Granted 20,000 Stock Option (right to buy) · Received 751 shares as a grant or award |
| 14 Feb 2024 |
Form 5: Shaver William M, Director
Granted 70,000 Stock Option (right to buy) · Received 1,066 shares as a grant or award · Received 20,111 shares as a grant or award |
| 14 Feb 2024 |
Form 5: Sanchez Merri, Director
Granted 10,000 Stock Option (right to buy) |
| 14 Feb 2024 |
Form 5: McEwen Robert Ross, Director
Granted 100,000 Stock Option (right to buy) |
| 14 Feb 2024 |
Form 5: Ing Perry, Chief Financial Officer
Granted 50,000 Stock Option (right to buy) · Received 852 shares as a grant or award · Received 14,699 shares as a grant or award |
| 14 Feb 2024 |
Form 5: Dunbar Robin E., Director
Granted 25,000 Stock Option (right to buy) |
| 14 Feb 2024 |
Form 5: Darveau-Garneau Nicolas, Director
Granted 20,000 Stock Option (right to buy) |
| 14 Feb 2024 |
Form 5: Brissenden Richard W., Director
Granted 25,000 Stock Option (right to buy) |
| 14 Feb 2024 |
Form 5: Ball Ian J, Director
Granted 10,000 Stock Option (right to buy) |
| 14 Feb 2024 |
Form 5: Ambrose Allen V, Director
Granted 25,000 Stock Option (right to buy) |
| 14 Feb 2024 |
Form 5: Diges Carmen L, General Counsel/Corp Sec
Granted 20,000 Stock Option (right to buy) · Received 965 shares as a grant or award · Received 10,017 shares as a grant or award |
| 21 Feb 2012 | Form 5: Bojtos Peter, Director |
Loading...
